30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Aralez Pharmaceuticals Canada Inc (SLRXF)

Track

Stock chart
Ticker: SLRXF
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Harris Robert Paul
Chief Executive Officer
1 purchase — total 250,000 USD
Buy 27 Feb 2013
Value US$351,299.31 | Price 454.76 | Shares 37,994
Buy 27 Feb 2013
Value US$247,416.27 | Price 64.49 | Shares 76,688
Buy 27 Feb 2013
Value US$3,307,911.69 | Price 396.90 | Shares 91,114
Buy 27 Feb 2013
Value US$100,000.00 | Price 0.40 | Shares 250,000
Buy 27 Feb 2013
Value US$500,000.00 | Price 0.40 | Shares 1,250,000
Buy 27 Feb 2013
Value US$25,000.00 | Price 0.40 | Shares 62,500
Buy 19 Nov 2012
Value US$35,000.00 | Price 0.35 | Shares 100,000
Buy 7 Sep 2012
Value US$12,500.00 | Price 0.50 | Shares 25,000
Buy 5 Sep 2012
Value US$5,050.00 | Price 0.51 | Shares 10,000
Buy 5 Sep 2012
Value US$14,700.00 | Price 0.49 | Shares 30,000
Buy 5 Sep 2012
Value US$22,250.00 | Price 0.50 | Shares 44,500
Buy 4 Sep 2012
Value US$10,250.00 | Price 0.50 | Shares 20,500
Buy 31 Aug 2012
Value US$7,350.00 | Price 0.49 | Shares 15,000
Buy 31 Aug 2012
Value US$2,445.00 | Price 0.49 | Shares 5,000
Buy 31 Aug 2012
Value US$6,900.00 | Price 0.46 | Shares 15,000
Buy 27 Aug 2012
Value US$23,746.32 | Price 0.52 | Shares 45,666
Buy 27 Aug 2012
Value US$1,275.00 | Price 0.51 | Shares 2,500
Buy 27 Aug 2012
Value US$120,225.00 | Price 0.50 | Shares 240,450
Buy 27 Aug 2012
Value US$9,994.00 | Price 0.50 | Shares 20,000
Buy 27 Aug 2012
Value US$9,423.66 | Price 0.50 | Shares 18,984
Buy 27 Aug 2012
Value US$12,878.00 | Price 0.47 | Shares 27,400
Buy 27 Aug 2012
Value US$11,250.00 | Price 0.45 | Shares 25,000
Buy 27 Aug 2012
Value US$2,200.00 | Price 0.44 | Shares 5,000
Buy 27 Aug 2012
Value US$2,150.00 | Price 0.43 | Shares 5,000
Buy 27 Aug 2012
Value US$4,250.00 | Price 0.43 | Shares 10,000
Buy 27 Aug 2012
Value US$7,600.00 | Price 0.38 | Shares 20,000
Buy 27 Aug 2012
Value US$15,200.00 | Price 0.38 | Shares 40,000
Buy 22 Mar 2012
Value US$308,000.00 | Price 0.56 | Shares 550,000
Buy 22 Mar 2012
Value US$308,000.00 | Price 0.56 | Shares 550,000
Buy 22 Mar 2012
Value US$504,000.00 | Price 0.56 | Shares 900,000
Sale 29 Nov 2011
Value US$13,750.00 | Price 0.55 | Shares 25,000
Sale 28 Nov 2011
Value US$13,250.00 | Price 0.53 | Shares 25,000
Sale 15 Nov 2011
Value US$7,137.50 | Price 0.50 | Shares 14,275
Sale 9 Nov 2011
Value US$3,650.00 | Price 0.50 | Shares 7,300
Sale 20 Oct 2011
Value US$4,890.90 | Price 0.51 | Shares 9,590
Sale 18 Oct 2011
Value US$4,500.00 | Price 0.45 | Shares 10,000
Sale 18 Oct 2011
Value US$4,300.00 | Price 0.43 | Shares 10,000
Buy 20 Jul 2011
Value US$7,824.40 | Price 0.62 | Shares 12,620
Sale 26 Aug 2010
Value US$227.90 | Price 0.86 | Shares 265
Sale 30 Jun 2010
Value US$19,620.00 | Price 0.90 | Shares 21,800
Buy 24 Sep 2007
Value US$2,860.00 | Price 0.52 | Shares 5,500
Buy 21 Sep 2007
Value US$2,400.00 | Price 0.48 | Shares 5,000
Buy 21 Sep 2007
Value US$2,300.00 | Price 0.46 | Shares 5,000
Buy 21 Sep 2007
Value US$2,160.00 | Price 0.48 | Shares 4,500
Sale 20 Jun 2006
Value US$10,080.00 | Price 0.84 | Shares 12,000
Buy 4 Jun 2004
Value US$1,628,000.00 | Price 1.48 | Shares 1,100,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-03-20 2013-02-27 B Purchase Harris Robert Paul

Chief Executive Officer

Executive Director
37,994 -12.5%
454.76
US$351,299 		37,994 -12.5% 454.76 US$351,299
2013-03-04 2013-02-27 B Purchase Goldman Steven Harold Non-Executive Director
76,688 -10.2%
64.49
US$247,416 		76,688 -10.2% 64.49 US$247,416
2013-03-04 2013-02-27 B Purchase Tenney Arnold

Chairman

Executive Director
87,149 +30.7%
155.30
US$2,060,774 		87,149 +30.7% 155.30 US$2,060,774
2013-03-04 2013-02-27 B Purchase Goldman Steven Harold Non-Executive Director
550,000 +44.7%
0.40
US$220,000 		550,000 +44.7% 0.40 US$220,000
2013-03-04 2013-02-27 B Purchase thrasher francis martin Non-Executive Director
1,250,000 +inf%
0.40
US$500,000 		1,250,000 +inf% 0.40 US$500,000
2013-03-04 2013-02-27 B Purchase Elora Financial Management Inc.

CFO

Executive Director Large shareholder
62,500 +0.9%
0.40
US$25,000 		62,500 +0.9% 0.40 US$25,000
2012-11-21 2012-11-19 B Purchase Goldman Steven Harold Non-Executive Director
100,000 +8.8%
0.35
US$35,000 		100,000 +8.8% 0.35 US$35,000
2012-09-12 2012-09-07 B Purchase Goldman Steven Harold Non-Executive Director
25,000 +2.5%
0.50
US$12,500 		25,000 +2.5% 0.50 US$12,500
2012-09-06 2012-09-05 B Purchase Goldman Steven Harold Non-Executive Director
10,000 +0.9%
0.51
US$5,050 		10,000 +0.9% 0.51 US$5,050
2012-09-06 2012-09-05 B Purchase Goldman Steven Harold Non-Executive Director
30,000 +2.8%
0.49
US$14,700 		30,000 +2.8% 0.49 US$14,700
2012-09-06 2012-09-05 B Purchase Goldman Steven Harold Non-Executive Director
44,500 +4.4%
0.50
US$22,250 		44,500 +4.4% 0.50 US$22,250
2012-09-06 2012-09-04 B Purchase Goldman Steven Harold Non-Executive Director
20,500 +2.0%
0.50
US$10,250 		20,500 +2.0% 0.50 US$10,250
2012-08-31 2012-08-31 B Purchase Goldman Steven Harold Non-Executive Director
15,000 +1.5%
0.49
US$7,350 		15,000 +1.5% 0.49 US$7,350
2012-08-31 2012-08-31 B Purchase Goldman Steven Harold Non-Executive Director
5,000 +0.5%
0.49
US$2,445 		5,000 +0.5% 0.49 US$2,445
2012-08-31 2012-08-31 B Purchase Goldman Steven Harold Non-Executive Director
15,000 +1.6%
0.46
US$6,900 		15,000 +1.6% 0.46 US$6,900
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
45,666 +12.9%
0.52
US$23,746 		45,666 +12.9% 0.52 US$23,746
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
2,500 +0.7%
0.51
US$1,275 		2,500 +0.7% 0.51 US$1,275
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
240,450 +215.9%
0.50
US$120,225 		240,450 +215.9% 0.50 US$120,225
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
20,000 +21.9%
0.50
US$9,994 		20,000 +21.9% 0.50 US$9,994
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
18,984 +26.2%
0.50
US$9,424 		18,984 +26.2% 0.50 US$9,424
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
27,400 +60.9%
0.47
US$12,878 		27,400 +60.9% 0.47 US$12,878
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
25,000 +125.0%
0.45
US$11,250 		25,000 +125.0% 0.45 US$11,250
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
5,000 +33.3%
0.44
US$2,200 		5,000 +33.3% 0.44 US$2,200
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
5,000 +50.0%
0.43
US$2,150 		5,000 +50.0% 0.43 US$2,150
2012-08-29 2012-08-27 B Purchase Tenney Arnold

Chairman

Executive Director
20,000 +2.3%
0.38
US$7,600 		20,000 +2.3% 0.38 US$7,600
2012-08-29 2012-08-27 B Purchase GREGORY JOHN M Non-Executive Director Large shareholder
10,000 +inf%
0.43
US$4,250 		10,000 +inf% 0.43 US$4,250
2012-08-29 2012-08-27 B Purchase Goldman Steven Harold Non-Executive Director
40,000 +4.3%
0.38
US$15,200 		40,000 +4.3% 0.38 US$15,200
2013-03-20 2012-03-22 B Purchase Harris Robert Paul

Chief Executive Officer

Executive Director
550,000 +7.1%
0.56
US$308,000 		550,000 +7.1% 0.56 US$308,000
2013-03-20 2012-03-22 B Purchase Harris Robert Paul

Chief Executive Officer

Executive Director
550,000 +7.7%
0.56
US$308,000 		550,000 +7.7% 0.56 US$308,000
2013-02-28 2012-03-22 B Purchase Elora Financial Management Inc.

CFO

Executive Director Large shareholder
900,000 +15.4%
0.56
US$504,000 		900,000 +15.4% 0.56 US$504,000
2011-12-06 2011-11-29 S Sale Riehl Peter Roy Large shareholder
25,000 -0.8%
0.55
US$13,750 		25,000 -0.8% 0.55 US$13,750
2011-12-06 2011-11-28 S Sale Riehl Peter Roy Large shareholder
25,000 -0.8%
0.53
US$13,250 		25,000 -0.8% 0.53 US$13,250
2011-12-01 2011-11-15 S Sale Riehl Peter Roy Large shareholder
14,275 -0.4%
0.50
US$7,138 		14,275 -0.4% 0.50 US$7,138
2011-12-01 2011-11-09 S Sale Riehl Peter Roy Large shareholder
7,300 -0.2%
0.50
US$3,650 		7,300 -0.2% 0.50 US$3,650
2011-10-26 2011-10-20 S Sale Riehl Peter Roy Large shareholder
9,590 -0.3%
0.51
US$4,891 		9,590 -0.3% 0.51 US$4,891
2011-10-26 2011-10-18 S Sale Riehl Peter Roy Large shareholder
10,000 -0.3%
0.45
US$4,500 		10,000 -0.3% 0.45 US$4,500
2011-10-26 2011-10-18 S Sale Riehl Peter Roy Large shareholder
10,000 -0.3%
0.43
US$4,300 		10,000 -0.3% 0.43 US$4,300
2011-07-28 2011-07-20 B Purchase Riehl Peter Roy Large shareholder
12,620 +0.4%
0.62
US$7,824 		12,620 +0.4% 0.62 US$7,824
2010-08-31 2010-08-26 S Sale Goldman Steven Harold Non-Executive Director
265 -0.1%
0.86
US$228 		265 -0.1% 0.86 US$228
2010-07-02 2010-06-30 S Sale Clarke Janice Marie

Chief Financial Officer

Officer
21,800 -21.3%
0.90
US$19,620 		21,800 -21.3% 0.90 US$19,620
2007-09-24 2007-09-24 B Purchase Clarke Janice Marie

Chief Financial Officer

Officer
5,500 +7.2%
0.52
US$2,860 		5,500 +7.2% 0.52 US$2,860
2007-09-24 2007-09-21 B Purchase Riehl Peter Roy

Chief Executive Officer

Executive Director
5,000 +0.3%
0.48
US$2,400 		5,000 +0.3% 0.48 US$2,400
2007-09-24 2007-09-21 B Purchase Riehl Peter Roy

Chief Executive Officer

Executive Director
5,000 +0.3%
0.46
US$2,300 		5,000 +0.3% 0.46 US$2,300
2007-09-24 2007-09-21 B Purchase Clarke Janice Marie

Chief Financial Officer

Officer
4,500 +6.2%
0.48
US$2,160 		4,500 +6.2% 0.48 US$2,160
2007-04-04 2006-06-20 S Sale Rosenkrantz David Aubrey Non-Executive Director
12,000 -10.9%
0.84
US$10,080 		12,000 -10.9% 0.84 US$10,080
2004-06-08 2004-06-04 B Purchase SJ STRATEGIC INVESTMENTS LLC Large shareholder
1,100,000 +26.9%
1.48
US$1,628,000 		1,100,000 +26.9% 1.48 US$1,628,000
Explore more

More insider trading research around Aralez Pharmaceuticals Canada Inc

More insider trades in United States
Insider trading in North America